Genprex Inc Global One Media Interview Transcript
Hello, everyone. Welcome to Global One Media's exclusive one-on-one interviews, with company executives sharing insights into their unique journey. I'm your host, Ashleigh Barry, and we're thrilled to welcome Ryan Confer, Chief Financial Officer at Genprex. It's a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes, to provide new therapies for large patient populations with cancer and diabetes, who currently have limited treatment options. They're listed on NASDAQ as GNPX. Ryan, thank you for being here today.
Yeah, thank you, Ashleigh, and I appreciate you guys having us.
Questions & Answers
Yeah, as we were saying, this is such an important mission. Let's start with an overview of Genprex, maybe explaining why you're specifically
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |